Vertu Motors Analyst Q&A: Management team drove efficiencies and cost savings (LON:VTU)

Vertu Motors plc (LON:VTU) is the topic of conversation when Zeus Capital’s Head of Research Mike Allen caught up with DirectorsTalk for an exclusive interview.

Q1: Mike, it looks like a great set results from Vertu Motors, what were the key highlights in your opinion?

A1: So, the results were very strong, they beat our forecast by 37%, that was our initial forecast when we reinstated forecasting October. We’ve then steadily upgraded those numbers and they beat our last forecast by 7%.

Clearly it was an unprecedented in a complex year for the group, the outperformance is come in lots of different way. Costs and efficiency has been one key trend for sure, they’ve also outperformed the markets in terms of volume activity and they’ve done very well on cash generation and debt reduction as well, over the period.

Q2: There was plenty to go on in the update, but what trends did you note?

A2: I think in terms of the used car market, obviously margins were very strong there, we’ve seen the supply shortages and that’s come through in margins, but also, they did deliver good volume growth given the context of the market there as well. New car market was a little bit tougher, but they outperformed that and I think aftersales was a robust performance as well.

But as I said before, a big delta of the outperformance is what they did on operating expenses and even when you strip out the government support that they did, they still delivered £10 million of annualised cost savings. So, the management team really dug into the detail of the business and drove efficiencies and cost saving.

Q3: Now, you mentioned earlier that they performed better than your expectations so does that mean that there’ve been changes to your forecasts?

A3: We have updated our forecast to reflect what they’ve delivered, we’re assuming now management to guide them between £24 and 28 million PBT in 2022, we’re looking at £26 million at the moment, that’s a strong upgrade on the number that we had in the last year. We’re assuming £28 million for the following year as well.

We are mindful of the supply shortages driven by global semiconductor shortages at the moment so we’ve been mindful when we’ve been putting those numbers together. It still equates to a 42% of upgrade to adjusted PBT in ’22 and bout 18% in 2023 as well so very strong upgrades.

Q4: Finally, what are your thoughts on Vertu Motors in terms of valuation?

A4: If we take it in a couple of steps really. First step, this business now has tangible net assets per share with 50p and the shares are still below that at the moment so I think that’s a very conservative starting point. We’ve then looked at our kind of intrinsic value modelling and we’ve looked at the business on a similar parts basis, DCF basis, and also mid cycle earnings multiples based on our current forecast.

The upshot of that analysis is we’re comfortable around 75p however, I think if you were to take a longer term view, and if you look at the historic peak earnings in the business and then look at the balance sheet capacity for investment in organic activities and in acquisitions, we think a blue sky target earnings of about 8.5p is achievable over the next couple of years. If we put that on a PE of 12 then we think that provides a sensible long-term price target of 102p per share.

So, there’s a lot to go for in this business, that’s kind of clearly improved and obviously developed itself during the pandemic so we think it’s very exciting times ahead for the company.

Click to view all articles for the EPIC: ,
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Vertu Motors Plc

    More articles like this

    Guild Esports sign two-year gaming chair sponsorship with Razer

    Guild Esports plc (LON:GILD; OTCQB: GULDF), a global teams organisation and lifestyle brand, has welcome Razer as the Company’s Official Gaming Chair Partner with the signing of a two-year global sponsorship deal. The total contract value, which

    Redde Northgate trading ahead of expectations

    Redde Northgate plc (LON:REDD), the leading integrated mobility solutions platform providing services across the vehicle lifecycle, has announced a trading update for the year ended 30 April 2022, ahead of its results for the year scheduled

    Inchcape

    Inchcape update on Russian operations

    Inchcape plc (LON:INCH) is deeply saddened by the ongoing conflict in Ukraine and the enormous humanitarian impact on all those affected. We share the hopes of the world for a peaceful resolution. In light of the current

    STRIX GROUP PLC ORD 1P

    Strix Group to conduct investor presentation on 31st March 2022

    Strix Group plc (LON:KETL), the global leader in the design, manufacture and supply of kettle safety controls and other complementary water temperature management components will be conducting an investor presentation covering their Full Year results to the period

    City of London Investment Group plc

    City of London Investment Group Barry Olliff increases holding

    City of London Investment Group plc (LON:CLIG), a leading specialist asset management group offering a range of institutional and retail products investing primarily in closed-end funds, stated that it has been notified that Stable View III LP,

    CentralNic

    CentralNic Group continue to beat expectations (Analyst Interview)

    CentralNic Group Plc (LON:CNIC) is the topic of conversation when Bob Liao Director and Research Analyst at Zeus Capital joins DirectorsTalk Interviews. Bob provides us with an overview of VGL, explains how the acquisition fits in with CentalNic’s business,

    Guild Esports wins fifth major trophy

    Guild Esports plc (LON:GILD; OTCQB: GULDF), a global team organisation and lifestyle brand, has announced that it has won its fifth major trophy after its Fortnite pro-player, Henrik Mclean (‘Hen’), achieved first place in the prestigious Fortnite

    Oncimmune signs new commercial follow-on contract 

    Oncimmune Holdings plc (LON:ONC), the leading global immunodiagnostics group, has announced the signing of a new commercial follow-on contract with a world-leading medical research organisation based in the US, to validate the findings from a previous